Free Trial

Akero Therapeutics (AKRO) SEC Filings & 10K Form

Akero Therapeutics logo
$42.02 -2.90 (-6.46%)
Closing price 05/6/2025 04:00 PM Eastern
Extended Trading
$42.02 0.00 (0.00%)
As of 05/6/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Akero Therapeutics SEC Filings

DateFilerForm TypeView
05/06/2025
3:41 PM
Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/28/2025
5:22 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
7:00 AM
Akero Therapeutics (Filer)
Form DEF 14A
04/28/2025
7:23 AM
Akero Therapeutics (Filer)
Form ARS
04/16/2025
5:00 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
5:00 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
5:00 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:24 PM
Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
6:42 PM
Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:30 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
8:18 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:24 PM
Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:30 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:33 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:18 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:00 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:30 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:55 PM
Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:56 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:05 PM
Akero Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
7:30 AM
Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
6:30 AM
Akero Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
4:31 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
11:58 AM
Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM
Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
02/11/2025
8:30 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
6:54 PM
Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
5:05 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:03 AM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
8:14 AM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
8:14 AM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
6:52 AM
Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
7:43 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
7:43 PM
Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
7:43 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
4:08 PM
Akero Therapeutics (Filer)
Form 424B5
01/27/2025
8:35 PM
Akero Therapeutics (Subject)
Form FWP
01/27/2025
5:07 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:08 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:53 PM
Akero Therapeutics (Filer)
Form 424B5
01/27/2025
3:23 PM
Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
01/27/2025
3:24 PM
Akero Therapeutics (Subject)
Yale Catriona (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
3:24 PM
Akero Therapeutics (Subject)
Yale Catriona (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
3:06 PM
Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
7:31 AM
Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
6:38 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
1:08 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
7:20 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
7:59 PM
Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
8:01 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
8:03 PM
Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
8:08 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
7:50 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
7:52 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
7:56 PM
Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
7:38 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
7:44 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
7:24 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
7:26 PM
Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
7:28 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
7:29 PM
Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:25 PM
Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
8:57 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:51 AM
Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
11/13/2024
8:45 AM
Akero Therapeutics (Subject)
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
11/08/2024
4:06 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
9:52 AM
Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/08/2024
6:30 AM
Akero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
6:19 AM
Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
4:01 PM
Akero Therapeutics (Subject)
Yale Catriona (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
8:00 AM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
8:04 AM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
7:59 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:46 PM
Akero Therapeutics (Subject)
Yale Catriona (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
7:57 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
10:13 AM
Akero Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
7:06 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
7:06 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:50 PM
Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
3:38 PM
Akero Therapeutics (Subject)
Yale Catriona (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
7:04 AM
Akero Therapeutics (Subject)
Yale Catriona (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:09 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:03 PM
Akero Therapeutics (Subject)
Young Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
5:00 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
8:19 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:34 PM
Akero Therapeutics (Subject)
Yale Catriona (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
4:14 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:16 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:10 PM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:11 PM
Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:13 PM
Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Virtually Limitless Energy? (Ad)

A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.

One company’s discovery could change power forever
09/09/2024
8:09 AM
Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
09/05/2024
3:05 PM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:08 PM
Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:30 PM
Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
10:11 AM
Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:32 PM
Akero Therapeutics (Subject)
White William Richard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:27 PM
Akero Therapeutics (Subject)
Yale Catriona (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
10:45 AM
Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
6:30 AM
Akero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AKRO) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners